Induction Therapy for Patients with Multiple Sclerosis: Why? When? How? Gilles EdanEmmanuelle Le Page Current Opinion Open access 09 May 2013 Pages: 403 - 409
Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention Mathieu NolletSamuel Leman Leading Article 09 May 2013 Pages: 411 - 422
The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain Meng HeChao DengXu-Feng Huang Review Article 03 May 2013 Pages: 423 - 434
The Long-Term Safety of Antiepileptic Drugs Athanasios GaitatzisJosemir W. Sander Review Article 15 May 2013 Pages: 435 - 455
Publication Bias, with a Focus on Psychiatry: Causes and Solutions Erick H. Turner Review Article 22 May 2013 Pages: 457 - 468
The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors George T. GrossbergFacundo ManesStephen M. Graham Original Research Article Open access 04 June 2013 Pages: 469 - 478
Loxapine Inhalation Powder: A Review of its Use in the Acute Treatment of Agitation in Patients with Bipolar Disorder or Schizophrenia Gillian M. Keating Adis Drug Evaluation 06 June 2013 Pages: 479 - 489
Erratum to: The Role of Antipsychotics in the Management of Fibromyalgia Elena P. CalandreFernando Rico-Villademoros Erratum 17 May 2013 Pages: 491 - 491